On Oct. 17, the Food and Drug Administration (FDA) announced that it has awarded more than $23 million in research grants over the next 4 years to boost the development of products for patients with rare diseases. Read more
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder